Navigation Links
Applying brakes to symptoms of Alzheimer's with a tiny implant

In what holds promise for a large number of Alzheimer's patients, a breakthrough has arrived in the form of an inch long contraption designed to be implanted under// the skin on the abdomen. Indeed a promising treatment option, this implant contains a medicine that is slowly pumped into the patient's blood stream. According to the results of the clinical trails of this implant, the medicine is capable of retarding the progress of the disease for up to a year.

Each contraption is designed to last up till 6 months, all the while letting out a consistent dosage to control the symptoms of Alzheimer's. Once the contents of device are completely used up, it simply blends into the blood stream, without causing any harm.

The greatest advantage in this device is that apart from obliterating the need for the daily or weekly drug injections, it will effectively offset the ups and downs in the symptoms, which normally occur with medicines that are swallowed or injected. The overriding benefit is the fact that patients in the throes of memory loss need not be concerned about ensuring regular intake of drugs.

Leuprolide acetate, the medicine which has been in use for over two decades to treat prostate cancer is now being used inside the implant and research has shown that is capable of retarding the progress of Alzheimer's.

Susanne Sorenson, head of research at the Alzheimer's society said 'Tests on mice have shown it is effective in reducing levels of a chemical strongly associated with Alzheimer's, and first tests on humans have indicated it could help slow the progression of the disease. But it's too early to tell if it will stop the disease developing.'


'"/>




Page: 1

Related medicine news :

1. Dialing On Cell Phones Or Applying Make-Up Increase Crash Risk
2. Cell transplants used to fend off Parkinsons symptoms
3. Occupational exposurer aises respiratory symptoms
4. New drug to multiple sclerosis symptoms
5. Warding off symptoms of premenstrual syndrome by combination therapy
6. Women who had stopped HRT get back their symptoms
7. Beat menopausal symptoms with low-dose estrogen
8. Dark chocolate can help ease symptoms of diarrhea
9. Synthetic protein found to relieve arthritis symptoms in animal model
10. Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea
11. Physical activity may help relieve gastrointestinal symptoms in obese people
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Super-Sod will ... and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home ... Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture from ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, ... Center on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar ... in our community. We are thrilled to participate in this event because we believe ...
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a leading ... spend management, today announced that Keppel Corporation has selected Apptricity Travel and Expense ... , “We are excited to announce the partnership between Keppel and Apptricity for ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal ... therapies for both rare and common malignancies, today ... B financing. The company intends to use the ... and TK216, and to advance preclinical development of ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody ...
(Date:2/22/2017)... R.I. , Feb. 22, 2017  CVS Pharmacy ... the removal of partially hydrogenated oils (PHO), the primary ... all its exclusive store brands food products. The retailer ... which are free from artificial trans fats. This comes a ... Drug Administration,s deadline of June 2018 for processed foods ...
(Date:2/22/2017)... , Colombie-Britannique, February 22, 2017 Des scanners sur ... vente en Europe , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , ... Vancouver , au Canada , a annoncé ... des Scanners Échographiques Sans fil Clarius C3 et L7, destinés à être ...
Breaking Medicine Technology: